Correspondence on ‘Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series’ by Siegert et al
Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · e117-e118
DOI: 10.1016/j.ard.2026.07.002 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Yan Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Zibo Central Hospital, Zibo, Shandong, China. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Zibo Central Hospital, Zibo, Shandong, China.
- Department of Respiratory Medicine, Wulian County People's Hospital, Rizhao, Shandong, China.
- Department of Dermatology, Zibo First Hospital, Zibo, Shandong, China. Electronic address: fengxingx1x12019@163.com.
Zitieren
APA
Li, Y., Ma, C., & Zhang, F. (2026). Correspondence on ‘Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series’ by Siegert et al. Annals of the Rheumatic Diseases, 85(11), e117-e118. https://doi.org/10.1016/j.ard.2026.07.002
Vancouver
Li Y, Ma C, Zhang F. Correspondence on ‘Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series’ by Siegert et al. Annals of the Rheumatic Diseases. 2026;85(11):e117-e118. doi:10.1016/j.ard.2026.07.002
BibTeX
@article{Li2026,
author = {Li, Yan and Ma, Chunyan and Zhang, Feng},
title = {Correspondence on ‘Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series’ by Siegert et al},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {11},
pages = {e117--e118},
doi = {10.1016/j.ard.2026.07.002}
}
EUVIMED